Showing results (111-120 of 117) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Lancet (London, England)|May 10, 2021
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trialAshesh B Jani, Eduard Schreibmann, Subir Goyal, et al.Neuro-Oncology Advances|April 6, 2022
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastomaKarthik Ramesh, Eric A Mellon, Saumya S Gurbani, et al.European Urology|December 18, 2025
[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 TrialAshesh B Jani, Vishal R Dhere, Subir Goyal, et al.Circulation|October 31, 2002
Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysisYoshihiro Morino, Hideaki Kaneda, Tim Fox, et al.Plant Biotechnology Journal|January 6, 2017
A single point mutation in Ms44 results in dominant male sterility and improves nitrogen use efficiency in maizeTim Fox, Jason DeBruin, Kristin Haug Collet, et al.American Journal of Nuclear Medicine and Molecular Imaging|January 24, 2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptakeDavid M Schuster, Pooneh A Taleghani, Peter T Nieh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.Pageof 12